Clinical Trial Update: Efficacy of Ranibizumab Therapy With Aflibercept in Patients With Diabetic Macular Edema [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of combined ranibizumab and aflibercept therapy in diabetic macular edema; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Aflibercept (Aflibercept)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Instituto de Olhos de Goiania | Conditions: Retinal Diseases | Phase 4 | Status: COMPLETED